For some patients, especially those with low energy tied to nutritional gaps, support can make it easier to stay consistent
[DOI] [PubMed] [Google Scholar] 37.Villar H.V., Fender H.R., Rayford P.L., Bloom S.R., Ramus N.I., Thompson J.C
Beyond weight loss, the SELECT trial showed semaglutide reduces major adverse cardiovascular events by 20 percent in patients with obesity and established cardiovascular disease, even without diabetes [Lincoff SELECT, NEJM 2023]
Lipids Lipids and fatty acids can affect glucose homeostasis by stimulating GLP secretion via free fatty acid receptors (FFARs) known as G protein-coupled receptors (GPCRs)
Deficiency of insulin-like growth factor 1 reduces sensitivity to aging-associated cardiomyocyte dysfunction
Vavilovskii Zhurnal Genet